HKSE - Delayed Quote HKD
Giant Biogene Holding Co., Ltd. (2367.HK)
82.450
+4.400
+(5.64%)
At close: 4:08:31 PM GMT+8
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Jianya Yan | CEO & Executive Chairman of the Board | 848.89k | -- | 1966 |
| Ms. Huijuan Zhang | CFO & Executive Director | 1.03M | -- | 1987 |
| Ms. Juan Ye | Senior VP & Executive Director | 1.03M | -- | 1972 |
| Ms. Juan Fang | Senior VP & Executive Director | 1.03M | -- | 1974 |
| Ms. Yajuan Yan | Senior Vice President | -- | -- | 1970 |
| Ms. Yubo Yan | Chief Product Officer, Joint Company Secretary & Executive Director | 388.99k | -- | 1996 |
| Dr. Daidi Fan | Chief Scientific Officer | -- | -- | 1967 |
| Mr. Zhiguang Duan | Senior Vice President | -- | -- | 1982 |
| Ms. Wing Yan Yuen FCIS, FCS | Joint Company Secretary | -- | -- | 1970 |
Giant Biogene Holding Co., Ltd.
No. 1855, Shanglin Yuan
7th Road Chang’an District
Xi'an
China
- Sector:
- Consumer Defensive
- Industry: Household & Personal Products
- Full Time Employees:
- 1,758
Description
Giant Biogene Holding Co., Ltd., an investment holding company, designs, develops, and manufactures skin treatment products with recombinant collagen in the People's Republic of China. It also develops and manufactures rare ginsenosides technology-based functional food products; and offers medical devices. The company offers its functional skincare products, medical dressings, and functional food products primarily under the Comfy, Collgene, Ke Yu, and SKIGIN brands. Giant Biogene Holding Co., Ltd. was founded in 2000 and is headquartered in Xi'an, the People's Republic of China.
Corporate Governance
Giant Biogene Holding Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
March 26, 2025 at 10:59 AM UTC
Giant Biogene Holding Co., Ltd. Earnings Date
June 17, 2025 at 12:00 AM UTC
Ex-Dividend Date
Recent Events
Recent Events Information Not Available
Related Tickers
1318.HK Mao Geping Cosmetics Co Ltd
98.800
-0.40%
2145.HK Shanghai Chicmax Cosmetic Co., Ltd.
71.900
+9.27%
603605.SS Proya Cosmetics Co.,Ltd.
99.20
+2.01%
6601.HK Cheerwin Group Limited
2.310
+0.87%
1044.HK HENGAN INT'L
22.300
-0.67%
EL The Estée Lauder Companies Inc.
65.36
+7.17%
ELF e.l.f. Beauty, Inc.
74.07
+10.82%
PG The Procter & Gamble Company
160.90
+2.06%
HIMS Hims & Hers Health, Inc.
55.21
+6.25%